Complement appears to be involved in the destruction of platelets in certain clinical disorders, such as quinidine purpura and post-transfusion purpura. In both disorders, the classical complement sequence is activated by antigen-antibody complexes. It has been suggested that the terminal components of the complement sequence insert into the hydrophobic core of cell surface membranes and that this process leads to cell lysis. Fluidity is a fundamental property of lipids within the membrane's hydrophobic core. To examine the interaction of complement with membranes, we investigated the effect of complement activation on the fluidity of human platelet membranes. Complement was fixed to platelets using a post-transfusion purpura antibody, and membrane lipid fluidity was assessed in terms of fluorescence anisotropy using two fluorescent probes, 1,6-diphenyl-1,3,5-hexatriene and 9-(12-anthroyl) stearic acid. Microviscosity, expressed in poise, was derived from the fluorescence anisotropy of 1,6-diphenyl-1,3,5-hexatriene.
A B S T R A C T Complement appears to be involved in the destruction of platelets in certain clinical disorders, such as quinidine purpura and post-transfusion purpura. In both disorders, the classical complement sequence is activated by antigen-antibody complexes. It has been suggested that the terminal components of the complement sequence insert into the hydrophobic core of cell surface membranes and that this process leads to cell lysis. Fluidity is a fundamental property of lipids within the membrane's hydrophobic core. To examine the interaction of complement with membranes, we investigated the effect of complement activation on the fluidity of human platelet membranes. Complement was fixed to platelets using a post-transfusion purpura antibody, and membrane lipid fluidity was assessed in terms of fluorescence anisotropy using two fluorescent probes, 1,6-diphenyl-1 ,3,5-hexatriene and 9-(12-anthroyl) stearic acid. Microviscosity, expressed in poise, was derived from the fluorescence anisotropy of 1,6-diphenyl-1,3,5-hexatriene.
Post-transfusion purpura antibody plus complement made platelet membranes more fluid as evidenced by a 21% decrease in anisotropy and a 35% decrease in microviscosity of platelets at 37°C, and this was associated with platelet lysis (51Cr release). Complement damage to platelets was accompanied by a 10-15% increase in AE, the fusion activation energy for microviscosity, indicating that complement not only decreased membrane microviscosity but also made membrane lipids less ordered. These changes were Received for publication 10 June 1977 and in revised form 2 November 1977. consistent and rapid, with platelet lysis and the reduction in microviscosity being half-maximal by 6 min. They were prevented by inactivation of complement with heat or with EDTA, and they were not observed when C5-deficient plasma was used as the complement source. Qualitatively similar changes in platelet membrane fluidity were observed when complement was fixed to platelets by a quinidine-dependent anti-platelet antibody rather than by post-transfusion purpura antibody. Post-transfusion purpura antibody plus complement also decreased the microviscosity of isolated platelet membranes. Moreover, the lipids extracted from platelets lysed by complement had a 22% decrease in microviscosity (P < 0.01), with no associated changes in the amount of cholesterol relative to phospholipid or in the amounts of the various phospholipids.
These studies demonstrate that lipids within the hydrophobic core of platelet membranes damaged by complement become more fluid, and this is associated with platelet lysis. These findings are consistent with the concept that the insertion of the terminal complement components into the platelet membrane bilayer perturbs lipid-lipid interactions within the membrane's hydrophobic core.
INTRODUCTION
The classical complement sequence (C1-9) is a multimolecular system of plasma glycoproteins which is activated by antigen-antibody complexes. Complement activation may result in the elaboration of biologically active polypeptides (C3a, C5a) that stimulate specialized cell functions, and it may also result in the assembly of a "membrane attack complex" (C5b-9) which damages cell membranes and thereby lyses cells (1) .
Human platelets are damaged by complement in vitro through activation of either the classical (2) alternative (3) complement pathways. In a clinical setting, lysis of platelets by complement appears to be responsible for thrombocytopenia in certain diseases, most notably, quinidine or quinine thrombocytopenia (4) and post-transfusion purpura (5) . Recent evidence indicates that membrane damage by complement requires the insertion of hydrophobic portions of the membrane attack complex inito the hydrophobic core of the cell membrane (6, 7) . Fluidity defines a fundamental property of membrane lipids within this core (8) .
The fluidity of cell membrane lipids has been evaluated in many types of eukaryote cells using membrane probes of the electron-spin resonance (9) and fluorescent (10) types. From these studies, the general concept has emerged that fluidity of the lipid bilayer is regulated within narrow limits, and if these limits are exceeded, abnormalities in membrane function result (11) . The precise mechanism whereby complement insertion disrupts membrane function is unknown. Complement lysis of sheep erythrocytes has been associated with increased fluidity of membrane lipids, as assessed by a spin-labeled phospholipid (12) . Therefore, we investigated the effect of complement activation on the fluidity of human platelet membranes. To do this, complement was activated in the presence of human platelets by human antiplatelet antibody from a patient with post-transfusion purpura and from a patient with quinidine thrombocytopenia. Platelet membrane lipid fluidity was assessed in terms of fluorescence anisotropy and micro-*viscosity using the hydrophobic fluorescent probe, 1,6-diphenyl-1,3,5,-hexatriene (DPH).1 METHODS Sources of complement-fixing anti-platelet antibody. Post-transfusion purpura plasnma (PTP plasma) was the source of antibody used in most of these studies. It was obtained from a patient whose illness conforms to the classic description of PTP of the PlAl type (5). Plasma was collected by therapeutic plasmapheresis on a Haemonetics model 30 Cell Separator Blood Processor (Haemonetics Corp., Natick, Mass.), collected into acid-citrate-dextrose (JA-25N Blood Pack, Fenwall Laboratories, Inc., Morton Grove, Ill.), and stored at -70(C until use. PTP plasma caused lysis (51Cr release) in vitro of platelets containing the PlAl antigen, whereas it failed to lyse PlAI-negative platelets and the patient's own platelets in vitro upon recovery. Several lines of evidence indicated that complement was required for platelet lysis. Platelet lysis did not proceed in a reaction mixture containing gel-filtered platelets and partially purified antibody in the absence of complement and did not proceed in the presence of plasmas deficient in Cl and C2 or selectively deficient in C4.2 The anti-platelet activity was 1Abbreviations used in this paper: AS, 9-(12-anthroyl) stearic acid; DPH, 1,6-diphenyl-1,3,5-hexatriene; AE, fusion activation energy for microviscositv; PTP, post-transfusion purpura.
tion.
partially purified by quaternary aminoethyl Sephadex and Sephadex G-200 chromatography and fractionated with monomeric IgG (13) . Although the PTP plasma also contained an antibody to HLA-B7, this was not responsible for platelet lysis, since platelets from donors lacking HLA-B7 were still lysed by this plasma. Plasma conitaining a (quinidine-dependent antiplatelet antibody was kindly supplied by Dr. Richard Aster (Milwaukee Blood Center, Milwaukee, Wis.).
Incubation of intact platelets wtith antibody and complement. The PlAl antigen is present on platelets of over 98% of the population (5), and the platelets of all donors in these experiments were lysed readily by PTP plasma in the presence of complement. Venous blood was obtained from healthy, fasting volunteers and collected through 19- gauge butterfly needles into plastic syringes and anticoagulated with heparin, 2 U/ml. This concentration of heparin had been shown previously to prevent thrombin generation but support complenment-dependent platelet lysis more efficiently than higher concentrations of heparin or conventional anticoagulant concentrations of citrate.2 All blood processing and incubations were carried out in plastic ware. Platelet-rich plasma was obtained by centrifugation of blood at room temperature for 10 min at 180 g. The remaining blood was cenitrifuged at 21,800 g for 20 min to obtain platelet-poor plasma. Platelets were counted (14) and platelet-rich plasma was adjusted withl platelet-poor plasma, when necessary, to 3-4 x 108 platelets/ml. In certain experiments, platelets were labeled with ['4C]serotonin (15) or 51Cr (16) before incubationi with antibody and complement.
Incubation mixtures (pH 7.4) contained PTP plasma and an equal volume of platelet-rich plasma, which contained platelets and fresh, heparinized plasma as a complement source. Mixtures were incubated for 1 h at 37°C in a shaking water bath (80 oscillations per min). "Control" incubation mixtures contained the same platelet-rich plasma and an equal volume of autologous or ABO-compatible acid-citratedextrose plasma rather than PTP plasma. After incubation, complement activation was stopped bv placing the tubes in ice and diluting the reaction mixtures with an isotonic, EDTA-containing platelet buffer ("wash" buffer) (17) . A single experiment wvas performed to test the effect of PTP antibody on platelet membrane fluidity in the presence of a complement source known to be deficient in C5 (18) . Platelets were gel-filtered through Sepharose 2B (19) in modified Tyrode's buffer (20) , containing 0.3% crystalline human serum albumin, 0.1% dextrose, and 2 mM MgCl2. They were incubated at 37°C for 1 h, with equal volumes of partially purified PTP antibody and heparinized C5-deficient human plasma. The results were compared with similarly treated platelets incubated with antibody and normal plasma.
Platelets were incubated with quinidine sulfate (2 mM), quinidine-dependent anti-platelet antibody, and complement as described by Aster et al. (2, 21) .
Incubation of platelet membranes with antibody and complement. Platelet membranes were isolated by the glycerol lysis method (22) , and washed twice at 4°C in the presence of proteolytic inhibitors (23) . Where indicated, platelets were also lysed by homogenization (20) . Membranes were suspended to a concentration of 500 ug membrane protein per ml in inhibitor-free, modified Tyrode's buffer, pH 7.4, (20). 1-mI membranes were incubated at 37°C with 9 ml PTP plasma and 4.5 ml fresh, heparinized plasma for membranes (100 A.g mcn('blranc proteimn/mI) aft(er achtl had bieent washed thiree timies wvitlb p)1telc t vvaish bulffer (17 (25, 26) . TFhe term, imembrane ftiuidit\-. is uisedi here as s\nomMuiiouS with l/mIicro)visco)sitv (27) .
Excited state lif'etimies t ) were estimatc(l fr-oni the relative fluioresecence initensities att ea,ch temperatiire and fromi a value of' f, ( (Table I) . Thlis deccrease wvas conisistenit anti significant (P < 0.001) (Fig.   1 ). The comple-ment-indluced chlanige in microvi scositv occutrredI rap)idly, aInd wvas halfln-axinmal by 6 No change in platelet of isolated platelet membranes with PTP plasma and iscosity was observed when platelets were complement consistently resulted in a decrease in y glycerol-loading or by homogenization. How-membrane microviscosity (P < 0.01) ( Fig. 3 ; Table I ). isruption of platelets with Triton X-100 (0.003 Complement-induced membrane damage resulted not ml) resulted in 84% 51Cr release and an 11% only in the bilayer of isolated membranes becoming ,e in microviscosity (P < 0.01). Thus, the more fluid, but the lipids extracted from comples in microviscosity caused by antibody and com-ment-damaged platelets were more fluid as well.
Lt were neither a universal concomitant of mem-Thus, platelets were ly'sed with PTP plasma and ysis nor were they unique to complement lysis. complement and their lipids were extracted, dispersed Letermine whether the effect of antibody and by sonication, and labeled with DPH. The microviscosity of the extracted lipids was 22% lower than the lipids of normal platelets ( Fig. 4 ; Table I ). The microviscosity of lipids of platelets incubated with complement' but in the absence of antibody was 1.81+0.05 poise and was comparable to that of normal platelet lipids (Table I) . The relationship between temperature anid microviscosity in platelets before and after complementmediated membrane damage is show7n in Fig. 5 than normal (Fig. 5) . Thus complement had a dual effect on platelet membrane lipids: it decreased their microviscosity and it made them less ordered. PTP antibody was not the only complementfixing anti-platelet antibody to decrease membrane viscosity. A quinidine-dependent anti-platelet antibody plus complement caused a 12% decrease in platelet microviscosity, and this was associated with the release of 44% platelet 51Cr. Moreover, the effect of complement on platelet membrane fluidity was demonstrable using a second hydrophobic fluorescent probe, AS. In two experiments, the fluorescence anisotropy of AS in platelets decreased 11% after incubation of these platelets with PTP plasma and complement.
Mechanism of the complement effect on platelet membrane fluidity. These studies demonstrate that the microenvironment of DPH in intact platelets, isolated platelet membranes, and extracted platelet lipids becomes markedly more fluid as a result of I/T x 10-3OK
FIGURE 5 The effect of PTP plasma and complement on platelet microviscosity and the fusion activation energy for microviscosity, AE. Although these data may be relevant to the mechanism of complement-induced membrane injury and cell lysis, several factors must be considered and controlled for when applying fluorescence polarization techniques to the study of biomembranes. Fluorescence measurements derived from intact platelets may not be indicative of probe rotation within the surface membrane alone, particularly since DPH may be distributed throughout surface and internal membranes of the platelet (10) . Studies in other complex cells have also demonstrated a generalized distribution for DPH (34, 36) . Therefore, we separated the platelet "'membrane fraction" from granule membranes, and demonstrated that isolated membranes were indeed more fluid after their interaction with antibody and complement.
Hydrophobic probes, such as DPH, label hydrophobic proteins as well as lipids. Thus it is possible that complement components which insert into the platelet membrane constitute a new "microenvironment" for DPH, thereby confounding interpretation of the fluorescence data with respect to rotational diffusion of the probe within the membrane lipid bilayer. This theoretical problem appears unlikely in the present study since the complement-induced changes in fluidity were also observed in sonicated lipids extracted from platelets.
Biomembranes obviously display a greater complexity and heterogeneity of lipid-protein and lipidlipid interactions compared to pure phospholipid dispersions (37) . The assessment of "microviscosity" by analysis of the rotational diffusion of DPH in biomembrane lipids by relating it to the fluorescence polarization and lifetime of the probe in paraffin oils is only semi-quantitative. Although it is useful to compare values of microviscosity in control platelets with values in the same platelets after some perturbation (i.e. complement), it may not be proper to consider the microviscositv values in units of poise as absolutely comparable to macroscopic systems. Nonetheless, our studies of human platelets with fluorescent probes are comparable to the spin-label studies of sheep erythrocvte membranes which demonstrate fluidization of the lipid bilaver by complement (12) .
Several factors are known to decrease membrane anisotropy and microviscosity. Interaction of membrane lipids (boundary lipids) with membrane proteins may contribute normally to the microviscosity value since extraction of lipids from membrane proteins results in a decrease in lipid microviscosity Platelet M\embrane Fluidity after Conmplenment Injury 5 587 (38, 39) . This was true in platelets as well; however the extracted lipids of platelets damaged by complement still were more fluid than normal platelet lipids (Fig. 4) . These data suggest that some change in lipid composition had occurred. Theoretically, platelet menl)rane lipids could be made more fluid bNy a decrease in the amounit of memnbrane cholesterol relative to phospholipid (10) or by a decrease in the amount of lecithin relative to sphingomvelin (40) . However, coomplement lsis was associated with no detectable change in the amount of cholesterol relative to phospholipid or in the relative distribution of the major phospholipid classes in platelet membranes. The precise mechanism whereby complement activation results in a greater fluidity of platelet membrane lipids remains unknown.
The changes in platelet membrane fluidity during complement lysis are not a general result of platelet disruption sinice glycerol lysis or homogenization did not affect membrane microviscosity. It has been suggested that the increased fluidity of the cell membrane by complement may be the proximate cause of membrane lysis (12) . Indeed, local anesthetics increase membrane fluidity at low concentrations (41) and cause membrane lysis at higher concentrations (42) . Moreover, Kinsky has suggested that the lytic action of complement resembles that of a detergent (43) and, in the present study, the detergent, Triton X-100 increased platelet membrane fluidity as it disrupted platelets. On the other hand, Mayer has theorized that the increased permeability of complementdamaged membranes might result from the formation of a hydrophobic channel formed by one or more of the terminal complement components (44) . Thus, whether the fluidity changes induced by complement are causative of lysis or merely a concomitant of the lytic process remains unknown.
An enzymatic degradation of phospholipids is another potential mechanism by which complement damages membranes. Complement activation can cause leakage from artificial lipid dispersions (liposomes) in the absence of protein (43) and lysolecithin, the product of phospholipase A activity, is a detergent (45) . However, careful studies with liposomes (43, 46) and Acholeplasma laidlawii (47) have failed to demonstrate phospholipase activity as a proximate cause of membrane lysis by complement. In addition, we found no evidence for lysolecithin generation in platelets during complement damage. These negative data make enzymatic degradation of phospholipids unlikely, but they do not unequivocally exclude this possibility, as they are limited by the sensitivity of the analytical techniques employed.
